Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?
about
On-chip screening for prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA.Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease.Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.
P2860
Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@en
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@nl
type
label
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@en
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@nl
prefLabel
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@en
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@nl
P2860
P1433
P1476
Prostate-specific antigen-base ...... rd millennium: useful or hype?
@en
P2093
Gian Cesare Guidi
Mario Plebani
P2860
P304
P356
10.1080/07853890903156468
P407
P577
2009-01-01T00:00:00Z